A Professional Service Provider for the Pharma Industry
There was not much for us to report on this summer that would interest our readership… Let’s skip the Fauci / Paul senate drama regarding the origins of Covid, with senator Paul taking the role of the Grand Inquisitor and Dr. Fauci the Fifth. The latest act in this screen Continue reading Avacopan / TAVNEOS Follow-Up
Lopsided Avacopan ADVOCATE Study Design Continue reading Avacopan ADVOCATE Study Design
We have to thank Liu and colleagues for a thorough review of pharmaceutical development activities in China and elsewhere during the last decade.[1] The authors reviewed a total of 34,844 Phase 1-3 trials, showing a significant uptick in studies initiated by Chinese companies. Compared to 2015, trial numbers have steadily Continue reading DRUG DEVELOPMENT IN CHINA – Moving Beyond the Me-Too Path